Ikena Oncology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 33.1%.

Top 25 shareholders own 80.14% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
20.5%	OrbiMed Advisors LLC	9,907,945	US$13.1m	3.7%	0.18%
10.4%	Atlas Venture L.P.	5,018,178	US$6.6m	0%	0.71%
9.88%	BVF Partners L.P.	4,769,164	US$6.3m	50.5%	0.16%
4.66%	Omega Fund Management, LLC	2,249,123	US$3.0m	0%	2.03%
4.42%	Bristol-Myers Squibb Company	2,133,142	US$2.8m	0%	no data
4.05%	CHI Advisors LLC	1,953,616	US$2.6m	-10.4%	0.87%
3.85%	BlackRock, Inc.	1,858,156	US$2.5m	28.5%	no data
3.16%	The Vanguard Group, Inc.	1,524,848	US$2.0m	12.7%	no data
2.74%	Verition Fund Management LLC	1,322,397	US$1.7m	-23.2%	0.02%
2.52%	Abigail Johnson	1,215,002	US$1.6m	0%	no data
2.52%	FMR LLC	1,215,002	US$1.6m	-71%	no data
2.07%	Artal Group S.A.	999,513	US$1.3m	-46%	0.04%
1.84%	Gilead Sciences, Inc.	886,544	US$1.2m	0%	no data
1.18%	New Enterprise Associates, Inc.	570,050	US$752.5k	214%	0.04%
1.1%	Geode Capital Management, LLC	529,369	US$698.8k	2.35%	no data
0.85%	State Street Global Advisors, Inc.	410,745	US$542.2k	3.45%	no data
0.77%	Laurion Capital Management LP	372,613	US$491.9k	-30.3%	0.02%
0.67%	Vestal Point Capital, LP	322,671	US$425.9k	0%	0.05%
0.6%	Adage Capital Management, L.P.	287,900	US$380.0k	-29.4%	no data
0.51%	Barclays PLC Private Banking & Investment Banking Investment	244,655	US$322.9k	18.5%	no data
0.49%	Northern Trust Global Investments	238,572	US$314.9k	20.5%	no data
0.43%	Anson Group	209,315	US$276.3k	0%	0.04%
0.37%	Citadel Advisors LLC	178,177	US$235.2k	-13.8%	no data
0.3%	Bridgeway Capital Management, LLC	143,550	US$189.5k	25.2%	no data
0.24%	Sofinnova Investment, Inc.	115,712	US$152.7k	0%	0.01%